Form 8-K - Current report:
SEC Accession No. 0000950170-24-136183
Filing Date
2024-12-13
Accepted
2024-12-13 16:05:11
Documents
12
Period of Report
2024-12-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20241212.htm   iXBRL 8-K 53765
2 EX-3.1 asmb-ex3_1.htm EX-3.1 303410
  Complete submission text file 0000950170-24-136183.txt   542255

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20241212.xsd EX-101.SCH 31688
14 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20241212_htm.xml XML 4891
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 241548334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)